Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

41.23. Analysis.

41.23

Comparison 41 Adverse events within two years: etanercept + disease‐modifying anti‐rheumatic drug (DMARD) vs. DMARD, Outcome 23 Pharyngitis or laryngitis.